LAUSR

Health technology assessment (HTA) is defined as a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased and robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient-focused and seek to achieve best value (EUnetHTA definition: https:// www.eunethta.eu/). HTA has been used as decision support for health policy since the early 1980s in some Scandinavian and Anglo-Saxon countries, but arrived in Austria (and other social insurance-based countries) much later due to a high level of decentralised and regional structures for decision-making. The initiative for founding an HTA institute in Austria came from a research funding institution rather than from health policy, when, in 2006, the Ludwig Boltzmann Gesellschaft established a purely academic HTA institute (the Ludwig Boltzmann Institute for HTA; LBIHTA). Austria was already a latecomer in introducing HTA at that time, but—as such—could learn from the experiences of other countries. The major lesson to be learnt was that HTA can make the biggest impact if it is employed in connection with a concrete health policy information need before decisions are to be taken and with policy instruments (e.g., benefit catalogues) already in place rather than with general health system research. Within the last 13 years, the need for evidence-based support for sometimes difficult reimbursement and investment or even disinvestment decisions in health care has increased. Because of this need to support Austrian health pol-